How Long Can You Live With Thyroid Cancer Without Treatment?

Thyroid cancer is generally considered a treatable condition, with most patients achieving excellent outcomes with timely diagnosis and treatment. However, the prognosis can vary significantly depending on the type and stage of thyroid cancer. Anaplastic thyroid cancer (ATC), the most aggressive form, highlights the challenges of untreated thyroid cancer. Using insights from the study published on PubMed Central (PMC8797284), this article delves into the life expectancy and outcomes for individuals with thyroid cancer who remain untreated.

Key Takeaways:

• Anaplastic Thyroid Cancer (ATC) is one of the most aggressive and lethal forms of thyroid cancer, with a mean untreated survival time of less than six months.
• Multimodal Treatment, including surgery, chemotherapy, radiotherapy, and tyrosine kinase inhibitors, significantly extends survival for ATC patients, with median survival reaching over three years in some cases.
• Timely Diagnosis and Treatment are crucial to managing thyroid cancer, as delaying or avoiding treatment leads to rapid progression and poor outcomes, especially for aggressive types like ATC.
• Type and Stage Matter: The prognosis varies based on the cancer type (e.g., papillary, follicular, medullary, or anaplastic) and stage at diagnosis. Slow-growing types may have better outcomes even without immediate treatment.
• Quality of Life Declines Without Treatment, as untreated thyroid cancer can cause severe symptoms like difficulty breathing, swallowing, and pain due to tumor growth.
• Local and Distant Spread Risks: Untreated thyroid cancer can spread locally to vital structures or distantly to organs like the lungs and bones, complicating management.
• Survival Rates Improve With Treatment: The referenced study showed 2- and 3-year survival rates of 59.7% and 35.8% in treated ATC patients, emphasizing the effectiveness of treatment.
• Even Aggressive Cancers Can Be Managed: While ATC is often incurable, comprehensive treatment significantly improves life expectancy and quality of life.
• Consult a Specialist Early: Early diagnosis and personalized treatment plans are vital for maximizing survival and minimizing complications.
• Prevention and Awareness: Understanding thyroid cancer symptoms and seeking medical advice early can prevent the disease from reaching advanced stages.

Know Anaplastic Thyroid Cancer

Anaplastic thyroid cancer (ATC) represents a rare but aggressive type of thyroid cancer. According to the referenced study, ATC typically has a mean survival time of approximately six months, even with treatment. The disease progresses rapidly and often presents with advanced local invasion or distant metastases at diagnosis, making it difficult to manage.

Survival Without Treatment

Without treatment, the prognosis for ATC patients is grim. The study highlighted the importance of multimodal therapy in extending survival. Patients who underwent surgery, chemotherapy, radiotherapy, or a combination of these treatments achieved a median survival time of 1,090 days. In contrast, untreated patients are unlikely to survive beyond six months due to the aggressive nature of the disease and its rapid spread.

Factors Influencing Survival

1. Type of Thyroid Cancer: While ATC is highly aggressive, other types, such as papillary and follicular thyroid cancers, have significantly better prognoses, even without immediate treatment.
2. Stage of Diagnosis: Advanced stages, especially those with distant metastases, tend to progress rapidly without intervention.
3. Overall Health: A patient’s age, overall health, and comorbidities also impact survival outcomes.
4. Tumor Biology: Some thyroid cancers are indolent and may remain asymptomatic for years, while others grow aggressively.

Why Treatment Matters

The study underscores the value of multimodal treatments in extending the lives of ATC patients. Treatments like surgery, radiotherapy, chemotherapy, and tyrosine kinase inhibitors significantly improve survival rates.

For example, the 2- and 3-year survival rates in the study were 59.7% and 35.8%, respectively, for those who received treatment. Without treatment, survival drops dramatically, often to less than a year.

Risks of Untreated Thyroid Cancer

1. Local Progression: Untreated thyroid cancer can grow locally, causing compression of vital structures in the neck, such as the airway and esophagus, leading to breathing and swallowing difficulties.
2. Distant Metastasis: Advanced thyroid cancers may spread to the lungs, bones, or other organs, complicating management and reducing survival chances.
3. Quality of Life Decline: The symptoms of untreated thyroid cancer, such as pain, voice changes, and difficulty breathing, significantly impact quality of life.

Also, check out the early stage symptoms of thyroid cancer in females.

Prognosis for Different Thyroid Cancer Types

• Papillary Thyroid Cancer (PTC): Often slow-growing, PTC can remain stable for years without treatment. However, untreated cases may eventually lead to complications or metastases.
• Follicular Thyroid Cancer (FTC): FTC has a slightly higher risk of metastasis compared to PTC but is often curable with treatment.
• Medullary Thyroid Cancer (MTC): Without treatment, MTC can spread to distant organs, shortening survival time.
• Anaplastic Thyroid Cancer (ATC): As highlighted in the study, ATC is the deadliest form of thyroid cancer, with a mean untreated survival time of less than six months.

Related:

1. When to Worry About Thyroid Nodules?
2. How to Shrink a Goiter Naturally
3. Exercise After Radiofrequency Ablation
4. Can You Live Without a Thyroid?
5. What Should TSH Levels Be After Thyroid Cancer?
6. How Fast Do Thyroid Nodules Grow?
7. How Do I Know If My Thyroid Nodule is Benign?
8. What Are the Symptoms of Cancerous Thyroid Nodules?
   
   

Conclusion

Survival with thyroid cancer depends significantly on the type, stage, and treatment approach. While some slow-growing thyroid cancers may not immediately threaten life, aggressive forms like anaplastic thyroid cancer require prompt and comprehensive treatment for improved outcomes.

The referenced study demonstrates that multimodal therapy can extend survival for ATC patients to over a year or more, highlighting the importance of early intervention. Without treatment, survival with thyroid cancer, especially ATC, is often short and fraught with complications. If you or someone you know has thyroid cancer symptoms, consult a healthcare professional to explore the best treatment options.

Reference

1. Lee H, Kim SY, Kim SM, Chang HJ, Lee YS, Park CS, Chang HS. Long-term survival of patients with anaplastic thyroid cancer after multimodal treatment. Transl Cancer Res. 2020 Sep;9(9):5430-5436. doi: 10.21037/tcr-20-1364. PMID: 35117908; PMCID: PMC8797284.
2. Tuttle RM, Haugen B, Perrier ND. Updated American Joint Committee on Cancer/Tumor-Node-Metastasis Staging System for Differentiated and Anaplastic Thyroid Cancer (Eighth Edition): What Changed and Why? Thyroid 2017;27:751-6.
    [DOI] [PMC free article] [PubMed] 
3. Mohebati A, Dilorenzo M, Palmer F, et al. Anaplastic thyroid carcinoma: a 25-year single-institution experience. Ann Surg Oncol 2014;21:1665-70. 10.1245/s10434-014-3545-5
    [DOI] [PubMed] 
4. Pozdeyev N, Gay LM, Sokol ES, et al. Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers. Clin Cancer Res 2018;24:3059-68. 10.1158/1078-0432.CCR-18-0373
    [DOI] [PMC free article] [PubMed]
5. Kim SM, Park KC, Jeon JY, et al. Potential anti-cancer effect of N-hydroxy-7-(2-naphthylthio) heptanomide (HNHA), a novel histone deacetylase inhibitor, for the treatment of thyroid cancer. BMC Cancer 2015;15:1003. 10.1186/s12885-015-1982-6
    [DOI] [PMC free article] [PubMed] [Google Scholar]